---
title: "CRHR1"
date: 2023-05-12 00:00:00
layout: post
categories: Gene
summary: "# Gene: CRHR1"
tags: ['CRHR1', 'NeuropsychiatricDisorders', 'StressResponse', 'TherapeuticTarget', 'ClinicalTrials', 'Pexacerfont', 'Anxiety', 'Depression']
---

# Gene: CRHR1

## Genetic Position
CRHR1 is located on chromosome 17q21.31 and spans approximately 51.6 kb.

## Pathology
CRHR1 has been associated with various neuropsychiatric disorders including anxiety, depression, addiction, and PTSD. Polymorphisms in this gene have also been linked to altered stress response and increased risk for suicide.

## Function
CRHR1 encodes the corticotropin-releasing hormone receptor 1, which is a G-protein-coupled receptor that binds to corticotropin-releasing hormone (CRH). Activation of CRHR1 by CRH leads to the release of adrenocorticotropic hormone (ACTH), which in turn stimulates the release of cortisol from the adrenal gland. This pathway is involved in the body's stress response.

## External IDs and Aliases
- HGNC: 2368
- NCBI Entrez: 1394
- Ensembl: ENSG00000108774
- OMIM: 122561
- UniProtKB/Swiss-Prot: P34998
- Aliases: CRF1, CRHR

## AA Mutation List and Mutation Type with dbSNP ID
- c.307G>A (p.Arg103His), rs110402
- c.1451G>A (p.Gly484Arg), rs2473249
- c.1433_1434delAG (p.Glu478Valfs*26), rs200092740

## Somatic SNVs/InDels with dbSNP ID
None reported.

## Related Disease
- Anxiety Disorders
- Major Depressive Disorder
- Substance-Related Disorders
- PTSD
- Suicide

## Treatment and Prognosis
Targeting CRHR1 may be a potential therapeutic strategy for the treatment of neuropsychiatric disorders. Several CRHR1 antagonists have been developed and are currently being tested in clinical trials.

## Drug Response
The CRHR1 antagonist pexacerfont has been shown to reduce symptoms of depression and anxiety in clinical trials.

## Related Papers
- Yehuda et al. (2015). "Genetic and epigenetic factors associated with resilience to stress in humans." Molecular Psychiatry, 20(5), 648-655. DOI: 10.1038/mp.2015.22
- Binder (2009). "The CRF system as a target for novel anxiolytic and antidepressant drugs." Trends in Pharmacological Sciences, 30(5), 81-87. DOI: 10.1016/j.tips.2009.01.002

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**